SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 10 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,610,000 | -65.4% | 2,680,000 | -66.1% | 0.33% | -35.9% |
| Q4 2021 | $7,533,000 | +13.8% | 7,897,000 | +15.9% | 0.51% | +1.4% |
| Q3 2021 | $6,618,000 | +5.1% | 6,813,000 | +7.4% | 0.51% | -11.8% |
| Q2 2021 | $6,298,000 | +4.0% | 6,345,000 | +2.1% | 0.57% | -18.7% |
| Q1 2021 | $6,056,000 | -16.6% | 6,212,000 | -18.1% | 0.71% | -6.7% |
| Q4 2020 | $7,260,000 | +81.2% | 7,586,000 | +76.9% | 0.76% | +59.7% |
| Q3 2020 | $4,006,000 | +12.3% | 4,289,000 | +7.3% | 0.47% | -7.2% |
| Q2 2020 | $3,568,000 | -19.5% | 3,999,000 | -26.1% | 0.51% | -22.9% |
| Q1 2020 | $4,431,000 | -35.5% | 5,414,000 | -27.7% | 0.66% | -25.7% |
| Q4 2019 | $6,870,000 | -18.0% | 7,486,000 | -16.0% | 0.89% | -6.9% |
| Q3 2019 | $8,375,000 | +11.3% | 8,910,000 | +16.7% | 0.96% | +12.3% |
| Q2 2019 | $7,524,000 | -6.1% | 7,637,000 | -7.3% | 0.85% | -17.2% |
| Q1 2019 | $8,015,000 | – | 8,234,000 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
| INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
| PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
| DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
| Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
| Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
| OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |